Alzheimer disease, memory and estrogen;Maladie d'Alzheimer, mémoire et estrogènes

Revue Neurologique

Volumn 166, Issue 4, 2010, Pages 377-388

  Blanc, F ^a,b   Poisbeau, P ^b   Sellal, F ^c,d   Tranchant, C ^a   de Seze, J ^a,b   Andre G ^e  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Hôpitaux Civils de Colmar   (France)

^d INSERM   (France)

^e Strasbourg   (France)

Author keywords

Alzheimer disease; Estradiol; Estrogen; Estrogen therapy; Memory

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL MODEL; COGNITION; DEMENTIA; HUMAN; IMAGING; MEMORY; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; POSTMENOPAUSE; PREVALENCE; REVIEW; SEX DIFFERENCE; STRUCTURE ACTIVITY RELATION;

AGED; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; CLINICAL TRIALS AS TOPIC; COGNITION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MICE; MIDDLE AGED; PARASYMPATHETIC NERVOUS SYSTEM; RATS; SEX FACTORS;

EID: 77950517063     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.07.010     Document Type: Review

References (130)

1. Ancelin M.L., and Ritchie K. Lifelong endocrine fluctuations and related cognitive disorders. Curr Pharm Des 11 (2005) 4229-4252
2. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R., et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. Neurology 53 (1999) 1992-1997
3. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. Effects of conjugated equine estrogen in post-menopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 291 (2004) 1701-1712
4. Bagger Y.Z., Tanko L.B., Alexandersen P., Qin G., and Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12 (2005) 12-17
5. Balthazart J., and Ball G.F. Is brain estradiol a hormone or a neurotransmitter?. Trends Neurosci 29 (2006) 241-249
6. Beck M., Bigl V., and Rossner S. Guinea pigs as a non transgenic model for APP processing in vitro and in vivo. Neurochem Res 28 (2003) 637-644
7. Bertram L., Lange C., Mullin K., Parkinson M., Hsiao M., Hogan M.F., et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83 (2008) 623-632
8. Binder E.F., Schechtman K.B., Birge S.J., Williams D.B., and Kohrt W.M. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38 (2001) 137-146
9. Boccardi M., Ghidoni R., Govoni S., Testa C., Benussi L., Bonetti M., et al. Effects of hormone therapy on brain morphology of healthy post-menopausal women: a Voxel-based morphometry study. Menopause 13 (2006) 584-591
10. Burkhardt M.S., Foster J.K., Laws S.M., Baker L.D., Craft S., Gandy S.E., et al. Estrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis 6 (2004) 221-228
11. Carroll J.C., and Pike C.J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 149 (2008) 2607-2611
12. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., Laferla F.M., et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27 (2007) 13357-13365
13. Carswell H.V., Dominiczak A.F., Garcia-Segura L.M., Harada N., Hutchison J.B., and Macrae I.M. Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol 96 (2005) 89-91
14. Chen S., Nilsen J., and Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 147 (2006) 5303-5313
15. Chetelat G., Landeau B., Eustache F., Mezenge F., Viader F., De La Sayette V., et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27 (2005) 934-946
16. Chrousos G.P., Torpy D.J., and Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 129 (1998) 229-240
17. Cordey M., and Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res 1045 (2005) 217-223
18. Cotman C.W. The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo. Neurochem Res 30 (2005) 877-881
19. Daniel J.M., Hulst J.L., and Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 147 (2006) 607-614
20. Desmond D.W., Moroney J.T., Sano M., and Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33 (2002) 2254-2260
21. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007) 734-746
22. Dumas J., Hancur-Bucci C., Naylor M., Sites C., and Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in post-menopausal women: evidence for the critical period hypothesis. Horm Behav 53 (2008) 159-169
23. Dumas J., Hancur-Bucci C., Naylor M., Sites C., and Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal post-menopausal women. Neuropsychopharmacology 31 (2006) 2065-2078
24. Dykens J.A., Moos W.H., and Howell N. Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann N Y Acad Sci 1052 (2005) 116-135
25. Eberling J.L., Wu C., Haan M.N., Mungas D., Buonocore M., and Jagust W.J. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 24 (2003) 725-732
26. Elliott E., Atlas R., Lange A., and Ginzburg I. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur J Neurosci 22 (2005) 1081-1089
27. Erickson K.I., Colcombe S.J., Raz N., Korol D.L., Scalf P., Webb A., et al. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging 26 (2005) 1205-1213
28. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., et al. Conjugated equine estrogens and global cognitive function in post-menopausal women: Women's health initiative memory study. J Am Med Assoc 291 (2004) 2959-2968
29. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R., Dartigues J.F., et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54 (2000) S10-S15
30. Fratiglioni L., Viitanen M., Von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997) 132-138
31. Frick K.M., Burlingame L.A., Arters J.A., and Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 95 (2000) 293-307
32. Fuh J.L., Wang S.J., Lu S.R., Juang K.D., and Lee S.J. Alterations in cognitive function during the menopausal transition. J Am Geriatr Soc 51 (2003) 431-432
33. Galea L.A., Lee T.T., Kostaras X., Sidhu J.A., and Barr A.M. High levels of estradiol impair spatial performance in the Morris water maze and increase "depressive-like" behaviors in the female meadow vole. Physiol Behav 77 (2002) 217-225
34. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., and Azcoitia I. Aromatase: a neuroprotective enzyme. Prog Neurobiol 71 (2003) 31-41
35. Geerlings M.I., Launer L.J., De Jong F.H., Ruitenberg A., Stijnen T., Van Swieten J.C., et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 53 (2003) 607-615
36. Gibbs R.B., and Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 74 (2003) 637-643
37. Gould E., Woolley C.S., Frankfurt M., and Mcewen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10 (1990) 1286-1291
38. Grady D., Yaffe K., Kristof M., Lin F., Richards C., and Barrett-Connor E. Effect of post-menopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med 113 (2002) 543-548
39. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18 (2000) 347-358
40. Greenfield J.P., Leung L.W., Cai D., Kaasik K., Gross R.S., Rodriguez-Boulan E., et al. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 277 (2002) 12128-12136
41. Hackman B.W., and Galbraith D. Replacement therapy and piperazine estrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin 4 (1976) 303-306
42. Hao J., Janssen W.G., Tang Y., Roberts J.A., Mckay H., Lasley B., et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 465 (2003) 540-550
43. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., and Farrer L.A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76 (2005) 103-105
44. Henderson V.W., Guthrie J.R., Dudley E.C., Burger H.G., and Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60 (2003) 1369-1371
45. Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54 (2000) 295-301
46. Hogervorst E., Williams J., Budge M., Riedel W., and Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101 (2000) 485-512
47. Horsburgh K., Macrae I.M., and Carswell H. Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab 22 (2002) 1189-1195
48. Iivonen S., Heikkinen T., Puolivali J., Helisalmi S., Hiltunen M., Soininen H., et al. Effects of estradiol on spatial learning, hippocampal cytochrome, P450, 19, and estrogen alpha and beta mRNA levels in ovariectomized female mice. Neuroscience 137 (2006) 1143-1152
49. Jaffe A.B., Toran-Allerand C.D., Greengard P., and Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 269 (1994) 13065-13068
50. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently post-menopausal women. Menopause 13 (2006) 411-422
51. Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 13 Suppl. 2 (2002) 48-52
52. Kapoor A., and Matthews S.G. Prenatal stress modifies behavior and hypothalamic-pituitary-adrenal function in female guinea pig offspring: effects of timing of prenatal stress and stage of reproductive cycle. Endocrinology (2008)
53. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 48 (1997) 1517-1521
54. Kok H.S., Kuh D., Cooper R., Van Der Schouw Y.T., Grobbee D.E., Wadsworth M.E., et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13 (2006) 19-27
55. Kok H.S., Van Asselt K.M., Van Der Schouw Y.T., Van Der Tweel I., Peeters P.H., Wilson P.W., et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47 (2006) 1976-1983
56. Kretz O., Fester L., Wehrenberg U., Zhou L., Brauckmann S., Zhao S., et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 24 (2004) 5913-5921
57. Krug R., Molle M., Dodt C., Fehm H.L., and Born J. Acute influences of estrogen and testosterone on divergent and convergent thinking in post-menopausal women. Neuropsychopharmacology 28 (2003) 1538-1545
58. Kugaya A., Epperson C.N., Zoghbi S., Van Dyck C.H., Hou Y., Fujita M., et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in post-menopausal women. Am J Psychiatry 160 (2003) 1522-1524
59. Kuh D., Butterworth S., Kok H., Richards M., Hardy R., Wadsworth M.E., et al. Childhood cognitive ability and age at menopause: evidence from two cohort studies. Menopause 12 (2005) 475-482
60. Laplante D.P., Barr R.G., Brunet A., Galbaud Du Fort G., Meaney M.L., Saucier J.F., et al. Stress during pregnancy affects general intellectual and language functioning in human toddlers. Pediatr Res 56 (2004) 400-410
61. Laplante D.P., Brunet A., Schmitz N., Ciampi A., and King S. Project Ice Storm: prenatal maternal stress affects cognitive and linguistic functioning in 5 1/2-year-old children. J Am Acad Child Adolesc Psychiatry 47 (2008) 1063-1072
62. Leblanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. J Am Med Assoc 285 (2001) 1489-1499
63. Lebrun C.E., Van Der Schouw Y.T., De Jong F.H., Pols H.A., Grobbee D.E., and Lamberts S.W. Endogenous estrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) 63 (2005) 50-55
64. Lee J., Fukumoto H., Orne J., Klucken J., Raju S., Vanderburg C.R., et al. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 194 (2005) 91-96
65. Lehericy S., Marjanska M., Mesrob L., Sarazin M., and Kinkingnehun S. Magnetic resonance imaging of Alzheimer's disease. Eur Radiol 17 (2007) 347-362
66. Linzmayer L., Semlitsch H.V., Saletu B., Bock G., Saletu-Zyhlarz G., Zoghlami A., et al. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung 51 (2001) 238-245
67. Liu F., Day M., Muniz L.C., Bitran D., Arias R., Revilla-Sanchez R., et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11 (2008) 334-343
68. Lupien S.J., Fiocco A., Wan N., Maheu F., Lord C., Schramek T., et al. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 30 (2005) 225-242
69. Maclusky N.J., Luine V.N., Hajszan T., and Leranth C. The 17alpha and 17beta isomers of estradiol both induce rapid spine synapse formation in the CA1 hippocampal subfield of ovariectomized female rats. Endocrinology 146 (2005) 287-293
70. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 138 (2006) 1027-1030
71. Marquis S., Moore M.M., Howieson D.B., Sexton G., Payami H., Kaye J.A., et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 59 (2002) 601-606
72. Matthews K., Cauley J., Yaffe K., and Zmuda J.M. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 47 (1999) 518-523
73. Meyer P.M., Powell L.H., Wilson R.S., Everson-Rose S.A., Kravitz H.M., Luborsky J.L., et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 61 (2003) 801-806
74. Mukai H., Tsurugizawa T., Murakami G., Kominami S., Ishii H., Ogiue-Ikeda M., et al. Rapid modulation of long-term depression and spinogenesis via synaptic estrogen receptors in hippocampal principal neurons. J Neurochem 100 (2007) 950-967
75. Mulnard R.A., Cotman C.W., Kawas C., Van Dyck C.H., Sano M., Doody R., et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. J Am Med Assoc 283 (2000) 1007-1015
76. Nathan B.P., Barsukova A.G., Shen F., Mcasey M., and Struble R.G. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145 (2004) 3065-3073
77. Nilsen J., and Brinton R.D. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143 (2002) 205-212
78. Norbury R., Travis M.J., Erlandsson K., Waddington W., Ell P.J., and Murphy D.G. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study. Horm Behav 51 (2007) 249-257
79. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A beta and synaptic dysfunction. Neuron 39 (2003) 409-421
80. Petanceska S.S., Nagy V., Frail D., and Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 54 (2000) 2212-2217
81. Phillips S.M., and Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 (1992) 485-495
82. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72 (1999) 1552-1563
83. Puder J.J., Freda P.U., Goland R.S., and Wardlaw S.L. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab 86 (2001) 2403-2408
84. Ramaroson H., Helmer C., Barberger-Gateau P., Letenneur L., and Dartigues Jf. Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort. Rev Neurol (Paris) 159 (2003) 405-411
85. Rapp P.R., Morrison J.H., and Roberts J.A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23 (2003) 5708-5714
86. Rasgon N.L., Silverman D., Siddarth P., Miller K., Ercoli L.M., Elman S., et al. Estrogen use and brain metabolic change in post-menopausal women. Neurobiol Aging 26 (2005) 229-235
87. Richards M., Kuh D., Hardy R., and Wadsworth M. Lifetime cognitive function and timing of the natural menopause. Neurology 53 (1999) 308-314
88. Rigaud A.S., Andre G., Vellas B., Touchon J., and Pere J.J. No additional benefit of HRT on response to rivastigmine in menopausal women with AD. Neurology 60 (2003) 148-149
89. Robertson D.M., Van Amelsvoort T., Daly E., Simmons A., Whitehead M., Morris R.G., et al. Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study. Neurology 57 (2001) 2114-2117
90. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., De Andrade M., et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69 (2007) 1074-1083
91. Rossouw J.E., Anderson G.L., Prentice R.L., Lacroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 288 (2002) 321-333
92. Sandstrom N.J., and Williams C.L. Spatial memory retention is enhanced by acute and continuous estradiol replacement. Horm Behav 45 (2004) 128-135
93. Saucedo R., Rico G., Basurto L., Ochoa R., and Zarate A. Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol Obstet Invest 53 (2002) 114-117
94. Scarabin P.Y., Oger E., Simon T., and Plu-Bureau G. Estrogen plus progestin and risk of venous thrombosis. J Am Med Assoc 293 (2005) 1322 [author reply 22-3]
95. Scharfman H.E., and Maclusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 27 (2006) 415-435
96. Schiff R., Bulpitt C.J., Wesnes K.A., and Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology 30 (2005) 309-315
97. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., et al. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 44 (1996) 1307-1313
98. Shaywitz S.E., Naftolin F., Zelterman D., Marchione K.E., Holahan J.M., Palter S.F., et al. Better oral reading and short-term memory in midlife, post-menopausal women taking estrogen. Menopause 10 (2003) 420-426
99. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., et al. Effect of estrogen on brain activation patterns in post-menopausal women during working memory tasks. J Am Med Assoc 281 (1999) 1197-1202
100. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 138 (2006) 1021-1026
101. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13 (1988) 345-357
102. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in post-menopausal women: Women's health initiative memory study. J Am Med Assoc 291 (2004) 2947-2958
103. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health Initiative memory study: a randomized controlled trial. J Am Med Assoc 289 (2003) 2651-2662
104. Simoncini T., Mannella P., Fornari L., Caruso A., Willis M.Y., Garibaldi S., et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145 (2004) 5745-5756
105. Smith Y.R., Minoshima S., Kuhl D.E., and Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy post-menopausal women. J Clin Endocrinol Metab 86 (2001) 679-684
106. Sohrabji F., and Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 27 (2006) 404-414
107. Sohrabji F., Miranda R.C., and Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 92 (1995) 11110-11114
108. Solum D.T., and Handa R.J. Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J Neurosci 22 (2002) 2650-2659
109. Srivastava R.A., Krul E.S., Lin R.C., and Schonfeld G. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by post-transcriptional mechanisms. Mol Cell Biochem 173 (1997) 161-168
110. Stevens M.C., Clark V.P., and Prestwood K.M. Low-dose estradiol alters brain activity. Psychiatry Res 139 (2005) 199-217
111. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
112. Thal L.J., Thomas R.G., Mulnard R., Sano M., Grundman M., and Schneider L. Estrogen levels do not correlate with improvement in cognition. Arch Neurol 60 (2003) 209-212
113. Thurlimann B., Keshaviah A., Coates A.S., Mouridsen H., Mauriac L., Forbes J.F., et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353 (2005) 2747-2757
114. Toran-Allerand C.D., Tinnikov A.A., Singh R.J., and Nethrapalli I.S. 17alpha-estradiol: a brain-active estrogen?. Endocrinology 146 (2005) 3843-3850
115. Veiga S., Melcangi R.C., Doncarlos L.L., Garcia-Segura L.M., and Azcoitia I. Sex hormones and brain aging. Exp Gerontol 39 (2004) 1623-1631
116. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., and Horwitz R.I. Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 192 (2005) 387-393
117. Walf A.A., Koonce C.J., and Frye C.A. Estradiol or diarylpropionitrile administration to wild type, but not estrogen receptor beta knockout, mice enhances performance in the object recognition and object placement tasks. Neurobiol Learn Mem 89 (2008) 513-521
118. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54 (2000) 2061-2066
119. Welberg L.A., and Seckl J.R. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13 (2001) 113-128
120. Whalley L.J., Fox H.C., Starr J.M., and Deary I.J. Age at natural menopause and cognition. Maturitas 49 (2004) 148-156
121. Whalley L.J., Starr J.M., Athawes R., Hunter D., Pattie A., and Deary I.J. Childhood mental ability and dementia. Neurology 55 (2000) 1455-1459
122. Wise P.M. Neuroendocrine modulation of the "menopause": insights into the aging brain. Am J Physiol 277 (1999) E965-E970
123. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4 (1998) 447-451
124. Yaffe K., Haan M., Byers A., Tangen C., and Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54 (2000) 1949-1954
125. Yaffe K., Lui L.Y., Grady D., Cauley J., Kramer J., and Cummings S.R. Cognitive decline in women in relation to non-protein-bound estradiol concentrations. Lancet 356 (2000) 708-712
126. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., et al. Brain estrogen deficiency accelerates A beta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 102 (2005) 19198-19203
127. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. J Am Med Assoc 288 (2002) 2123-2129
128. Zhao L., O'neill K., and Diaz Brinton R. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res Brain Res Rev 49 (2005) 472-493
129. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., et al. Modulation of A beta peptides by estrogen in mouse models. J Neurochem 80 (2002) 191-196
130. Zwain I.H., and Yen S.S. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140 (1999) 880-887